Table 2.
Disorder | Mechanism | Total Serum Bilirubin Level (mg/dL) | Treatment |
---|---|---|---|
Gilbert’s syndrome | Mutation in UGT1A1 causing activity <33% normal | Up to 4 | None |
Crigler‐Najjar syndrome type 1 | UGT1A1 activity absent | Usually 20‐40 | Phototherapy |
Exchange transfusions | |||
Liver transplant | |||
Crigler‐Najjar syndrome type 2 | UGT1A1 activity <10% normal | Usually <20 | Phenobarbital |
DJ | MRP2 receptor mutation impairing transport across canalicular membrane | Usually 2‐5 | None |
Rotor syndrome | OATP1B1 and OATP1B3 mutations affecting reuptake of conjugated bilirubin by hepatocytes | Usually 2‐5 | None |